348 related articles for article (PubMed ID: 16716460)
1. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
Cohen D; Muhsen Kh; Aboudy Y; Harari H; Mendelson E; Green MS
Vaccine; 2006 Jul; 24(27-28):5604-8. PubMed ID: 16716460
[TBL] [Abstract][Full Text] [Related]
2. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
Vaccine; 2012 Nov; 30(50):7260-4. PubMed ID: 23063839
[TBL] [Abstract][Full Text] [Related]
3. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran.
Doroudchi M; Dehaghani AS; Emad K; Ghaderi AA
East Mediterr Health J; 2001; 7(1-2):128-38. PubMed ID: 12596962
[TBL] [Abstract][Full Text] [Related]
4. Success and failure of a rubella immunization programme.
Swartz TA; Porath EB; Hornstein L
Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682
[TBL] [Abstract][Full Text] [Related]
5. Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.
Huerta M; Davidovitch N; Ankol OE; Zaaide Y; Grotto I; Balicer RD; Zangvil E
Prev Med; 2004 Dec; 39(6):1223-6. PubMed ID: 15539059
[TBL] [Abstract][Full Text] [Related]
6. The 2001 serological survey in the Czech Republic--rubella.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S42-9. PubMed ID: 15080259
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.
Smits G; Mollema L; Hahné S; de Melker H; Tcherniaeva I; van der Klis F; Berbers G
Vaccine; 2014 Apr; 32(16):1890-5. PubMed ID: 24513012
[TBL] [Abstract][Full Text] [Related]
9. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains].
Zou J; Senecal J; Morvan A; Roussey A
Ann Pediatr (Paris); 1976 Feb; 23(2):111-8. PubMed ID: 16104238
[No Abstract] [Full Text] [Related]
10. Rubella seroprevalence among women aged 15-39 years in Morocco.
Caidi H; Bloom S; Azilmaat M; Benjouad A; Reef S; El Aouad R
East Mediterr Health J; 2009; 15(3):526-31. PubMed ID: 19731768
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of rubella IgG antibodies among Syrian females of childbearing age.
Barah F; Chehada AG
Saudi Med J; 2010 Jan; 31(1):78-81. PubMed ID: 20062905
[TBL] [Abstract][Full Text] [Related]
12. Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey.
Yalcin A; Caliskan D; Isik A
East Mediterr Health J; 2008; 14(5):1036-43. PubMed ID: 19161075
[TBL] [Abstract][Full Text] [Related]
13. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey?
Aksakal FN; Maral I; Cirak MY; Aygun R
Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522
[TBL] [Abstract][Full Text] [Related]
14. [Immune response of rubella vaccine in the populations with different age groups].
Xiong XW; Diao LD; Yan XL
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
[TBL] [Abstract][Full Text] [Related]
15. An outbreak of rubella in the Federation of Bosnia and Herzegovina between December 2009 and May 2010 indicates failure to vaccinate during wartime (1992-1995).
Hukic M; Hübschen JM; Seremet M; Salimovic-Besic I; Mulaomerovic M; Mehinovic N; Karakas S; Charpentier E; Muller CP
Epidemiol Infect; 2012 Mar; 140(3):447-53. PubMed ID: 21524344
[TBL] [Abstract][Full Text] [Related]
16. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.
Vijayalakshmi P; Anuradha R; Prakash K; Narendran K; Ravindran M; Prajna L; Brown D; Robertson SE
Bull World Health Organ; 2004 Apr; 82(4):259-64. PubMed ID: 15259254
[TBL] [Abstract][Full Text] [Related]
17. Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey.
Kanbur NO; Derman O; Kutluk T; Kinik E
Jpn J Infect Dis; 2003 Feb; 56(1):23-5. PubMed ID: 12711822
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of rubella virus infection among female residents on the offshore islets of Taiwan.
Lin DB; Chen CJ
J Trop Med Hyg; 1994 Apr; 97(2):75-80. PubMed ID: 8170006
[TBL] [Abstract][Full Text] [Related]
19. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
